Kevin Muñoz

Kevin Muñoz

Direktor/Vorstandsmitglied bei SILO PHARMA, INC.

Vermögen: - $ am 31.05.2024

46 Jahre
Consumer Services
Health Technology

Ursprung des Netzwerks ersten Grades von Kevin Muñoz

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 5
Physical Medicine & Rehab. Center, P.A.
1
Private Company 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Kevin Muñoz

UnternehmenSektorVerknüpfte PersonenHauptposition
HOTH THERAPEUTICS, INC. Pharmaceuticals: Major

Wayne Linsley

Jeff Pavell

Director/Board Member

Director/Board Member

SOLIGENIX, INC. Pharmaceuticals: Major

James Kuo

Chairman

Specialty Telecommunications

Wayne Linsley

Corporate Officer/Principal

PANBELA THERAPEUTICS, INC. Pharmaceuticals: Major

Daniel Ryweck

Director of Finance/CFO

The Curtis L. Carlson School of Management College/University

Daniel Ryweck

Undergraduate Degree

MILL CITY VENTURES III, LTD. Finance/Rental/Leasing

Daniel Ryweck

Comptroller/Controller/Auditor

KONATEL, INC. Wireless Telecommunications

Daniel Ryweck

Director/Board Member

Siena College College/University

Wayne Linsley

Undergraduate Degree

Investment Managers

Wayne Linsley

Chief Operating Officer

Barney School of Business College/University

Eric Weisblum

Undergraduate Degree

Specialty Telecommunications

Wayne Linsley

Corporate Officer/Principal

Specialty Telecommunications

Wayne Linsley

Sales & Marketing

DATCHAT, INC. Packaged Software

Wayne Linsley

Director/Board Member

Flagship Advisory & Management Group LLC

Wayne Linsley

Corporate Officer/Principal

Executive Outsource Group, Inc.

Wayne Linsley

Chief Executive Officer

FOXWAYNE ENTERPRISES ACQUISITION CORP. Financial Conglomerates

Jeff Pavell

Director/Board Member

Hospital/Nursing Management

Jeff Pavell

Corporate Officer/Principal

New York College of Osteopathic Medicine College/University

Jeff Pavell

Doctorate Degree

John Hopkins University Atlantic Basin Policy Institute College/University

Jeff Pavell

Undergraduate Degree

Center For Advanced Surgery LLC

Jeff Pavell

Corporate Officer/Principal

DOMINARI HOLDINGS INC. Biotechnology

Eric Weisblum

Director/Board Member

Other Consumer Services

Eric Weisblum

Director/Board Member

Cysteine Pharma, Inc.

James Kuo

Chairman

Miscellaneous Commercial Services

James Kuo

Chief Executive Officer

Industrial Specialties

James Kuo

Founder

Investment Managers

James Kuo

Corporate Officer/Principal

Haverford College College/University

James Kuo

Undergraduate Degree

Medical Specialties

James Kuo

President

WINDTREE THERAPEUTICS, INC. Pharmaceuticals: Major

James Kuo

Chief Executive Officer

MSK Pharma LLC

James Kuo

Chairman

MYRIAD GENETICS, INC. Medical Specialties

James Kuo

Corporate Officer/Principal

THERIVA BIOLOGICS, INC. Pharmaceuticals: Major

James Kuo

Chief Executive Officer

Jaws Capital Partners LLC

Eric Weisblum

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

James Kuo

Masters Business Admin

PFIZER, INC. Pharmaceuticals: Major

James Kuo

Corporate Officer/Principal

Financial Conglomerates

James Kuo

Corporate Officer/Principal

IMMUNOPRECISE ANTIBODIES LTD. Biotechnology

James Kuo

Chairman

Pharmaceuticals: Major

James Kuo

Chief Executive Officer

TRYPTAMINE THERAPEUTICS LIMITED Pharmaceuticals: Major

James Kuo

Founder

Biotechnology

James Kuo

Chief Executive Officer

PHARNEXT SCA Biotechnology

James Kuo

Director/Board Member

University of Pennsylvania Medical Center College/University

James Kuo

Doctorate Degree

PHYSICAL MEDICINE & REHABILITATION CENTER PA

Jeff Pavell

Corporate Officer/Principal

Statistik

International

Vereinigte Staaten 45
Kanada 3
Finnland 2
Frankreich 2

Sektoral

Health Technology 17
Consumer Services 10
Finance 8
Communications 5
Technology Services 3

Operativ

Director/Board Member 15
Corporate Officer/Principal 12
Chief Executive Officer 11
Chairman 9
Independent Dir/Board Member 9
  1. Börse
  2. Insiders
  3. Kevin Muñoz
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT